Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

155.54 +5.59 (+3.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,016,260
Open 148.66
Bid (Size) 154.62 (2)
Ask (Size) 155.00 (1)
Prev. Close 149.95
Today's Range 146.84 - 158.79
52wk Range 115.61 - 497.49
Shares Outstanding 400,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily
This Is What Whales Are Betting On Moderna
Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga

Performance

YTD
-33.83%
-33.83%
1 Month
+11.10%
+11.10%
3 Month
-4.02%
-4.02%
6 Month
-33.30%
-33.30%
1 Year
-33.34%
-33.34%

More News

Read More
10 Hot Growth Stocks That Have Dropped 60% From Their 52-Week High
Via Talk Markets
Peering Into Moderna's Recent Short Interest
Via Benzinga
7 Best Healthcare Stocks to Buy Now
Via InvestorPlace
Why Is Novavax (NVAX) Stock Up 10% Today?
Via InvestorPlace
Stock Market Rally Under Pressure; Micron, GM, Nike, RH Warn: Weekly Review
Via Investor's Business Daily
What Are Whales Doing With Moderna
Via Benzinga
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
Via Benzinga
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
Via Investor's Business Daily
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
Via InvestorPlace
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
Via Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
Via Investor's Business Daily
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
Via Benzinga
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
Via Investor's Business Daily
What Are Whales Doing With Moderna
Via Benzinga
Walmart And 3 Other Stocks Insiders Are Selling
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Via InvestorPlace
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
Via Investor's Business Daily
Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says
Via Benzinga
This Is What Whales Are Betting On Moderna
Via Benzinga
So What's Going On With Moderna Shares Rising Today?
Via Benzinga
Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants
Via Benzinga
Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple's Tim Cook Says 'Stay Tuned' On AR/MR And Other Top Financial Stories Wednesday, June 22
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.